(Il Sole 24 Ore Radiocor) - Milano, 13 mag - Zydus Worldwide, a subsidiary of Zydus Lifesciences, agreed to buy pharmaceutical company Assertio Holdings for 166.4 million dollars.

The Zydus offer of 23.50 dollars per share in cash represents a 7.8% premium to a prior Garda agreement worth 21.80 per share and a 76% premium to Assertio's unaffected closing stock price on March 20.

The Assertio board determined that the Zydus offer is superior and authorized the company to terminate the.

agreement with Garda.

(RADIOCOR) 13-05-26 19:19:45 (0759) 5 NNNN